{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:18:44Z","timestamp":1790849924534,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006485","name":"National Institute for Genetic Engineering and Biotechnology","doi-asserted-by":"crossref","award":["1296"],"award-info":[{"award-number":["1296"]}],"id":[{"id":"10.13039\/501100006485","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men and is projected to cause approximately 35,250 deaths in 2024. The utility of total prostate-specific antigen (PSA) testing as a routine screening tool remains controversial due to limited specificity. Therefore, the identification of novel, noninvasive biomarkers is essential for improving early diagnosis. This study aimed to evaluate the methylation status of a specific CpG dinucleotide within the <jats:italic>SPDEF<\/jats:italic> (SAM-pointed domain-containing ETS transcription factor) gene promoter in blood leukocytes of PCa patients, using benign prostatic hyperplasia (BPH) samples as a control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Peripheral blood samples were collected from 360 men, including 180 diagnosed with PCa and 180 with BPH. A target CpG dinucleotide (cg11346722) in the <jats:italic>SPDEF<\/jats:italic> promoter was selected based on analysis of The Cancer Genome Atlas (TCGA) data. Methylation levels were assessed using methylation-sensitive restriction enzyme PCR (MSRE-PCR) and quantitative PCR (qPCR). Associations between methylation and clinical parameters\u2014tumor stage (TS), histological grade, and total PSA levels\u2014were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean methylation level at the <jats:italic>SPDEF<\/jats:italic> CpG site was significantly lower in PCa patients (hypomethylation: 92\u2009\u00b1\u200911.76%) compared to BPH controls (15.5\u2009\u00b1\u200915.12%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Receiver operating characteristic (ROC) curve analysis demonstrated that <jats:italic>SPDEF<\/jats:italic> hypomethylation discriminated PCa from BPH with 98.3% sensitivity and 98.3% specificity at a\u2009&lt;\u200955% methylation cutoff. A significant inverse correlation was observed between <jats:italic>SPDEF<\/jats:italic> methylation and both tumor stage (TS) and grade, whereas no correlation was found with total PSA levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Hypomethylation of a specific CpG dinucleotide in the <jats:italic>SPDEF<\/jats:italic> promoter may serve as a promising noninvasive blood-based biomarker for the early detection and clinical stratification of prostate cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12894-025-01824-5","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:01:53Z","timestamp":1748836913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CpG dinucleotide methylation of the SPDEF gene as a blood-based epigenetic biomarker for prostate cancer diagnosis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4574-2927","authenticated-orcid":false,"given":"Mohammad Vahid","family":"Ahmadianpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2526-4884","authenticated-orcid":false,"given":"Seyed Ahmad","family":"Aleyasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"1824_CR1","unstructured":"American Cancer Society. 2024-Cancer-Facts-and-Figures-Acs. Cancer Facts and Figures. 2024:4\u20135."},{"key":"1824_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate Cancer. World J Oncol. 2019;10:63\u201389.","journal-title":"World J Oncol"},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"1824_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/iju.13734","volume":"25","author":"K Fujita","year":"2018","unstructured":"Fujita K, Nonomura N. Urinary biomarkers of prostate cancer. Int J Urol. 2018;25:770\u20139.","journal-title":"Int J Urol"},{"key":"1824_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/pcan.2016.59","volume":"20","author":"RJ Hendriks","year":"2017","unstructured":"Hendriks RJ, Van Oort IM, Schalken JA. Blood-based and urinary prostate cancer biomarkers: A review and comparison of novel biomarkers for detection and treatment decisions. Prostate Cancer Prostatic Dis. 2017;20:12\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1824_CR6","doi-asserted-by":"publisher","first-page":"8954","DOI":"10.1158\/0008-5472.CAN-07-6088","volume":"68","author":"S Yegnasubramanian","year":"2008","unstructured":"Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate Cancer progression than CpG Island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 2008;68:8954\u201367.","journal-title":"Cancer Res"},{"key":"1824_CR7","doi-asserted-by":"crossref","unstructured":"Vatanmakanian M, Steffan JJ, Koul S, Ochoa AC, Chaturvedi LS, Koul HK. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer. Front Endocrinol (Lausanne). 2023;14.","DOI":"10.3389\/fendo.2023.1156120"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40572-015-0050-3","volume":"2","author":"EA Houseman","year":"2015","unstructured":"Houseman EA, Kim S, Kelsey KT, Wiencke JK. DNA methylation in whole blood: uses and challenges. Curr Environ Heal Rep. 2015;2:145\u201354.","journal-title":"Curr Environ Heal Rep"},{"key":"1824_CR9","first-page":"3039","volume":"18","author":"P Boonsongserm","year":"2019","unstructured":"Boonsongserm P, Angsuwatcharakon P, Puttipanyalears C, Aporntewan C, Kongruttanachok N, Aksornkitti V, et al. Tumor-induced DNA methylation in the white blood cells of patients with colorectal cancer. Oncol Lett. 2019;18:3039\u201348.","journal-title":"Oncol Lett"},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"9042","DOI":"10.1002\/jcb.27161","volume":"119","author":"J Wu","year":"2018","unstructured":"Wu J, Qin W, Wang Y, Sadik A, Liu J, Wang Y, et al. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1. J Cell Biochem. 2018;119:9042\u201354.","journal-title":"J Cell Biochem"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.2147\/CMAR.S243748","volume":"12","author":"T Ye","year":"2020","unstructured":"Ye T, Feng J, Wan X, Xie D, Liu J. Double agent: SPDEF gene with both oncogenic and tumor-suppressor functions in breast cancer. Cancer Manag Res. 2020;12:3891\u2013902.","journal-title":"Cancer Manag Res"},{"key":"1824_CR12","doi-asserted-by":"publisher","first-page":"12222","DOI":"10.1074\/jbc.M112.434225","volume":"288","author":"M Pal","year":"2013","unstructured":"Pal M, Koul S, Koul HK. The transcription factor sterile alpha motif (SAM) pointed domain-containing Ets transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells. J Biol Chem. 2013;288:12222\u201331.","journal-title":"J Biol Chem"},{"key":"1824_CR13","doi-asserted-by":"crossref","unstructured":"Vatanmakanian M, Koul S, Yousefi H, Santra M, Alahari S, Koul H. Role of SPDEF gene enhancer and promoter methylation in prostate cancer cell metastasis and therapeutic resistance. FASEB J. 2021;35:fasebj.2021.35.S1.04735.","DOI":"10.1096\/fasebj.2021.35.S1.04735"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"1156120","DOI":"10.3389\/fendo.2023.1156120","volume":"14","author":"M Vatanmakanian","year":"2023","unstructured":"Vatanmakanian M, Steffan JJ, Koul S, Ochoa AC, Chaturvedi LS, Koul HK. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer. Front Endocrinol (Lausanne). 2023;14:1156120.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"e16289","DOI":"10.1097\/MD.0000000000016289","volume":"98","author":"Y-F Lu","year":"2019","unstructured":"Lu Y-F, Zhang Q, Chen H-Y, Chen J-Y, Pan Y, Xu C-C, et al. Improving the detection rate of prostate cancer in the Gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen\u2013age volume. Med (Baltim). 2019;98:e16289.","journal-title":"Med (Baltim)"},{"key":"1824_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.ju.0000145883.01068.5f","volume":"173","author":"S Loeb","year":"2005","unstructured":"Loeb S, Han M, Roehl KA, Antenor Joa V, Catalona WJ. Accuracy of prostate weight Estimation by digital rectal examination versus transrectal ultrasonography. J Urol. 2005;173:63\u20135.","journal-title":"J Urol"},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Ge D, Lu C. The SMART app: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics Chromatin. 2019;12:71.","journal-title":"Epigenetics Chromatin"},{"key":"1824_CR19","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1093\/nar\/gni092","volume":"33","author":"AA Melnikov","year":"2005","unstructured":"Melnikov AA. MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Res. 2005;33:e93\u201393.","journal-title":"Nucleic Acids Res"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1093\/nar\/gni092","volume":"33","author":"AA Melnikov","year":"2005","unstructured":"Melnikov AA, Gartenhaus RB, Levenson AS, Motchoulskaia NA, Levenson Chernokhvostov VV. MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Res. 2005;33:e93.","journal-title":"Nucleic Acids Res"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1746-1596-7-56","volume":"7","author":"S Shen","year":"2012","unstructured":"Shen S, Qin D. Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis. Diagn Pathol. 2012;7:56.","journal-title":"Diagn Pathol"},{"key":"1824_CR22","first-page":"721","volume":"84","author":"D Wallwiener","year":"1989","unstructured":"Wallwiener D, Balde MD, Stolz W, Plantener G, Bastert G. Application of the neodymium-Yag laser in treating adhesions. Rev Fr Gynecol Obstet. 1989;84:721\u20133.","journal-title":"Rev Fr Gynecol Obstet"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"e0135058","DOI":"10.1371\/journal.pone.0135058","volume":"10","author":"CA Leontiou","year":"2015","unstructured":"Leontiou CA, Hadjidaniel MD, Mina P, Antoniou P, Ioannides M, Patsalis PC. Bisulfite conversion of DNA: performance comparison of different kits and methylation quantitation of epigenetic biomarkers that have the potential to be used in Non-Invasive prenatal testing. PLoS ONE. 2015;10:e0135058.","journal-title":"PLoS ONE"},{"key":"1824_CR24","doi-asserted-by":"publisher","first-page":"15785","DOI":"10.1073\/pnas.0507816102","volume":"102","author":"M Ehrich","year":"2005","unstructured":"Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci. 2005;102:15785\u201390.","journal-title":"Proc Natl Acad Sci"},{"key":"1824_CR25","doi-asserted-by":"publisher","unstructured":"Vatanmakanian M, Steffan JJ, Koul S, Ochoa AC, Chaturvedi LS and Koul HK. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer. Front. Endocrinol. 2023;14:1156120. https:\/\/doi.org\/10.3389\/fendo.2023.1156120","DOI":"10.3389\/fendo.2023.1156120"},{"key":"1824_CR26","doi-asserted-by":"crossref","unstructured":"Chen J, Hao P, Zheng T, Zhang Y. miR\u2013628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway. Exp Ther Med. 2019;:1005\u201312.","DOI":"10.3892\/etm.2019.7682"},{"key":"1824_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1200\/EDBK_159248","volume":"36","author":"H Beltran","year":"2016","unstructured":"Beltran H, Antonarakis ES, Morris MJ, Attard G. Emerging molecular biomarkers in advanced prostate cancer: translation to the clinic. Am Soc Clin Oncol Educ B. 2016;36:131\u201341.","journal-title":"Am Soc Clin Oncol Educ B"},{"key":"1824_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4137\/BMI.S16199","volume":"9","author":"DA Ovchinnikov","year":"2014","unstructured":"Ovchinnikov DA, Wan Y, Coman WB, Pandit P, Cooper-White JJ, Herman JG, et al. DNA methylation at the novel CpG sites in the promoter of MED15\/PCQAP gene as a biomarker for head and neck cancers. Biomark Insights. 2014;9:53\u201360.","journal-title":"Biomark Insights"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1111\/jcmm.16760","volume":"25","author":"T Ye","year":"2021","unstructured":"Ye T, Li J, Feng J, Guo J, Wan X, Xie D, et al. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance. J Cell Mol Med. 2021;25:7307\u201320.","journal-title":"J Cell Mol Med"},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"29968","DOI":"10.1074\/jbc.M112.379396","volume":"287","author":"JJ Steffan","year":"2012","unstructured":"Steffan JJ, Koul S, Meacham RB, Koul HK. The transcription factor SPDEF suppresses prostate tumor metastasis. J Biol Chem. 2012;287:29968\u201378.","journal-title":"J Biol Chem"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/01.pgp.0000225386.41244.bd","volume":"26","author":"KJ Rodabaugh","year":"2007","unstructured":"Rodabaugh KJ, Mhawech-Fauceglia P, Groth J, Lele S, Sood AK. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors. Int J Gynecol Pathol. 2007;26:10\u20135.","journal-title":"Int J Gynecol Pathol"},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/1541-7786.MCR-18-0010","volume":"16","author":"F Wang","year":"2018","unstructured":"Wang F, Koul S, Shanmugam PST, Dong Q, Koul HK. Prostate-Derived Ets factor (PDEF) inhibits metastasis by inducing epithelial\/luminal phenotype in prostate Cancer cells. Mol Cancer Res. 2018;16:1430\u201340.","journal-title":"Mol Cancer Res"},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1158\/0008-5472.CAN-04-0799","volume":"64","author":"MO Hoque","year":"2004","unstructured":"Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal Cancer. Cancer Res. 2004;64:5511\u20137.","journal-title":"Cancer Res"},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"12797","DOI":"10.3390\/ijms241612797","volume":"24","author":"G Rafikova","year":"2023","unstructured":"Rafikova G, Gilyazova I, Enikeeva K, Pavlov V, Kzhyshkowska J. Prostate cancer: genetics, epigenetics and the need for immunological biomarkers. Int J Mol Sci. 2023;24:12797.","journal-title":"Int J Mol Sci"},{"key":"1824_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10408363.2017.1410520","volume":"54","author":"JL Garc\u00eda-Gim\u00e9nez","year":"2017","unstructured":"Garc\u00eda-Gim\u00e9nez JL, Seco-Cervera M, Tollefsbol TO, Rom\u00e1-Mateo C, Peir\u00f3-Chova L, Lapunzina P, et al. Epigenetic biomarkers: current strategies and future challenges for their use in the clinical laboratory. Crit Rev Clin Lab Sci. 2017;54:529\u201350.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/gm491","volume":"5","author":"Y Aoki","year":"2013","unstructured":"Aoki Y, Nojima M, Suzuki H, Yasui H, Maruyama R, Yamamoto E, et al. Correction: genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma. Genome Med. 2013;5:88.","journal-title":"Genome Med"},{"key":"1824_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12885-018-4089-z","volume":"18","author":"M Nojima","year":"2018","unstructured":"Nojima M, Iwasaki M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, et al. Correlation between global methylation level of peripheral blood leukocytes and serum C reactive protein level modified by MTHFR polymorphism: a cross-sectional study. BMC Cancer. 2018;18:184.","journal-title":"BMC Cancer"},{"key":"1824_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.18.484951","author":"C Tonelli","year":"2022","unstructured":"Tonelli C, Yordanov GN, Hao Y, Desch\u00eanes A, Klingbeil O, Tuveson DA. SPDEF promotes the classical subtype of pancreatic ductal adenocarcinoma. BioRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.03.18.484951.","journal-title":"BioRxiv"},{"key":"1824_CR39","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1158\/0008-5472.CAN-04-4407","volume":"65","author":"D Lodygin","year":"2005","unstructured":"Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate Cancer. Cancer Res. 2005;65:4218\u201327.","journal-title":"Cancer Res"},{"key":"1824_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/his.12008","volume":"62","author":"L Egevad","year":"2013","unstructured":"Egevad L, Ahmad AS, Algaba F, Berney DM, Boccon-Gibod L, Comp\u00e9rat E, et al. Standardization of Gleason grading among 337 European pathologists. Histopathology. 2013;62:247\u201356.","journal-title":"Histopathology"},{"key":"1824_CR41","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/jamia\/ocac141","volume":"29","author":"SH Song","year":"2022","unstructured":"Song SH, Kim H, Kim JK, Lee H, Oh JJ, Lee S-C, et al. A smart, practical, deep learning-based clinical decision support tool for patients in the prostate-specific antigen Gray zone: model development and validation. J Am Med Inf Assoc. 2022;29:1949\u201357.","journal-title":"J Am Med Inf Assoc"},{"key":"1824_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1004656","volume":"10","author":"XH Cheng","year":"2014","unstructured":"Cheng XH, Black M, Ustiyan V, Le T, Fulford L, Sridharan A, et al. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene. PLoS Genet. 2014;10:1\u201314.","journal-title":"PLoS Genet"},{"key":"1824_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cam4.22","volume":"1","author":"E Olkhov-Mitsel","year":"2012","unstructured":"Olkhov-Mitsel E, Bapat B. Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med. 2012;1:237\u201360.","journal-title":"Cancer Med"},{"key":"1824_CR44","doi-asserted-by":"crossref","unstructured":"Beikircher G, Pulverer W, Hofner M, Noehammer C, Weinhaeusel A. Multiplexed and sensitive DNA methylation testing using methylation-Sensitive restriction enzymes MSRE-qPCR. 2018. pp. 407\u201324.","DOI":"10.1007\/978-1-4939-7481-8_21"},{"key":"1824_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1023\/A:1025103319328","volume":"4","author":"C Dahl","year":"2003","unstructured":"Dahl C, Guldberg P. DNA methylation analysis techniques. Biogerontology. 2003;4:233\u201350.","journal-title":"Biogerontology"},{"key":"1824_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.yexmp.2011.05.001","volume":"91","author":"D Hua","year":"2011","unstructured":"Hua D, Hu Y, Wu Y-Y, Cheng Z-H, Yu J, Du X, et al. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma. Exp Mol Pathol. 2011;91:455\u201360.","journal-title":"Exp Mol Pathol"},{"key":"1824_CR47","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/ijms18040735","volume":"18","author":"K Yokoi","year":"2017","unstructured":"Yokoi K, Yamashita K, Watanabe M. Analysis of DNA methylation status in bodily fluids for early detection of Cancer. Int J Mol Sci. 2017;18:735.","journal-title":"Int J Mol Sci"},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s10038-022-01092-3","volume":"68","author":"E Gowdini","year":"2023","unstructured":"Gowdini E, Aleyasin SA, Ramezani N, Nafisi N, Tutuni M. DOK7 CpG hypermethylation in blood leukocytes as an epigenetic biomarker for acquired Tamoxifen resistant in breast cancer. J Hum Genet. 2023;68:33\u20138.","journal-title":"J Hum Genet"},{"key":"1824_CR49","doi-asserted-by":"crossref","unstructured":"Boroujeni ZN, Shirkavand A, Aleyasin A. Evaluation of aberrant methylation of RASSF1A, BCL-XL, ITGA6, TCF3 and SNAIL2 genes in peripheral blood leukocyte DNA in breast Cancer patients. J Mol Biomark Diagn. 2018;09.","DOI":"10.4172\/2155-9929.1000378"},{"key":"1824_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13148-018-0564-2","volume":"10","author":"C Moreira-Barbosa","year":"2018","unstructured":"Moreira-Barbosa C, Barros-Silva D, Costa-Pinheiro P, Torres-Ferreira J, Const\u00e2ncio V, Freitas R, et al. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients. Clin Epigenetics. 2018;10:132.","journal-title":"Clin Epigenetics"},{"key":"1824_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40364-014-0025-9","volume":"2","author":"I Brikun","year":"2014","unstructured":"Brikun I, Nusskern D, Gillen D, Lynn A, Murtagh D, Feczko J, et al. A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients. Biomark Res. 2014;2:25.","journal-title":"Biomark Res"},{"key":"1824_CR52","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/sj.bjc.6603767","volume":"96","author":"AS Perry","year":"2007","unstructured":"Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RWG, et al. In Silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. Br J Cancer. 2007;96:1587\u201394.","journal-title":"Br J Cancer"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01824-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T16:02:09Z","timestamp":1748880129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01824-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01824-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The Ethics Committee of the National Institute of Genetics, Engineering, and Biotechnology (NIGEB) in Tehran, Iran granted official approval for this study (Ethical Code: IR.A.2016,8,23). All participants in the study were fully informed of their participation and signed provided informed consent in accordance with ethical protocols. The consent for participation has provided as related information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}},{"value":"The consent for publication has provided as related information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}